The Increasing Burden of Direct and Indirect Costs of IBD – Looking for Potential Solutions
The Lancet Gastroenterology & Hepatology has published a report on IBD, which examines the cost-effectiveness of treatments and provides recommendations for implementing more affordable strategies in the future. The report was presented at ECCO23 by Johan Burisch.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
